This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Comparison of two Siemen System B.brillant and the Revelation
Timeframe: From enrollment to the end of study at 18 months
Namaijah Faison Clinical Research Coordinator